Express Scripts Rises After Increase in Prescriptions

Express Scripts Holding Co., the U.S.’s largest pharmacy benefit manager after buying Medco Health Solutions Inc., rose the most in five weeks after the company reported prescription volume increased more than analysts expected.

Express Scripts gained 1.4 percent to $55.10 at 4 p.m. in New York trading today. The stock has declined 6.8 percent in the past 12 months.

The volume of adjusted prescription claims Express Scripts handled during the first quarter increased 3.6 percent to about 193 million from a year earlier, the St. Louis-based company said yesterday. Revenue increased 9.4 percent to $12.1 billion, beating analysts’ estimates of $11.5 billion.

“They reassured everybody that everything’s on track” with the merger, analyst Dave Shove of BMO Capital Markets in New York said in a phone interview. “And the quarter on scrip metrics was good. The stock’s lifting on all of that.”

The company shipped 14 million prescriptions to customers by mail, a 6 percent increase from a year earlier that was helped by Walgreen Co. (WAG)’s decision to withdraw its drug stores from Express Scripts’ network, Chief Executive Officer George Paz said on a conference call with analysts today.

Profit excluding one-time items was 73 cents per share, missing analysts’ average estimate of 77 cents.

To contact the reporter on this story: Alex Wayne in Washington at awayne3@bloomberg.net

To contact the editor responsible for this story: Reg Gale at rgale5@bloomberg.net

Press spacebar to pause and continue. Press esc to stop.

Bloomberg reserves the right to remove comments but is under no obligation to do so, or to explain individual moderation decisions.

Please enable JavaScript to view the comments powered by Disqus.